OC
Oarsman Capital’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Buy |
1,889
+7
| +0.4% | +$5.46K | 0.23% | 84 |
|
|
2025
Q1 | $1.55M | Sell |
1,882
-65
| -3% | -$53.7K | 0.28% | 76 |
|
|
2024
Q4 | $1.5M | Sell |
1,947
-85
| -4% | -$65.6K | 0.26% | 76 |
|
|
2024
Q3 | $1.8M | Sell |
2,032
-30
| -1% | -$26.6K | 0.33% | 60 |
|
|
2024
Q2 | $1.87M | Hold |
2,062
| – | – | 0.41% | 53 |
|
|
2024
Q1 | $1.6M | Sell |
2,062
-525
| -20% | -$408K | 0.38% | 60 |
|
|
2023
Q4 | $1.51M | Buy |
2,587
+732
| +39% | +$427K | 0.4% | 58 |
|
|
2023
Q3 | $996K | Hold |
1,855
| – | – | 0.42% | 65 |
|
|
2023
Q2 | $870K | Hold |
1,855
| – | – | 0.38% | 72 |
|
|
2023
Q1 | $637K | Hold |
1,855
| – | – | 0.3% | 81 |
|
|
2022
Q4 | $679K | Buy |
1,855
+20
| +1% | +$7.32K | 0.35% | 76 |
|
|
2022
Q3 | $593K | Buy |
1,835
+100
| +6% | +$32.3K | 0.32% | 83 |
|
|
2022
Q2 | $563K | Hold |
1,735
| – | – | 0.28% | 91 |
|
|
2022
Q1 | $497K | Hold |
1,735
| – | – | 0.19% | 115 |
|
|
2021
Q4 | $479K | Hold |
1,735
| – | – | 0.19% | 121 |
|
|
2021
Q3 | $401K | Hold |
1,735
| – | – | 0.16% | 137 |
|
|
2021
Q2 | $398K | Hold |
1,735
| – | – | 0.16% | 136 |
|
|
2021
Q1 | $324K | Buy |
1,735
+375
| +28% | +$70K | 0.14% | 139 |
|
|
2020
Q4 | $230K | Sell |
1,360
-50
| -4% | -$8.46K | 0.09% | 160 |
|
|
2020
Q3 | $209K | Hold |
1,410
| – | – | 0.09% | 158 |
|
|
2020
Q2 | $231K | Buy |
+1,410
| New | +$231K | 0.11% | 143 |
|